| MASMX | VSCIX | MASMX / VSCIX | |
| Total Expense Ratio | 1.35 | 0.04 | 3,375% |
| Annual Report Gross Expense Ratio | 1.35 | 0.04 | 3,375% |
| Fund Existence | 6 years | 29 years | - |
| Gain YTD | 4.721 | 5.535 | 85% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 156M | 162B | 0% |
| Annual Yield % from dividends | 0.00 | 1.28 | - |
| Returns for 1 year | -13.55 | 10.72 | -126% |
| Returns for 3 years | -0.91 | 33.12 | -3% |
| Returns for 5 years | -27.27 | 31.94 | -85% |
| Returns for 10 years | 21.50 | 186.94 | 12% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EITEX | 52.65 | 0.62 | +1.19% |
| Parametric Tax-Managed Emerg Mkt I | |||
| QSMRX | 22.41 | 0.21 | +0.95% |
| AQR Small Cap Momentum Style R6 | |||
| ETNHX | 51.17 | 0.44 | +0.87% |
| Eventide Healthcare & Life Sciences N | |||
| RCEAX | 13.06 | 0.05 | +0.38% |
| RBC China Equity A | |||
| FDTTX | 26.87 | N/A | N/A |
| Fidelity Advisor Capital Development A | |||